Effect of Catheter Device Closure of Atrial Septal
Defect on Diastolic Mitral Annular Motion
Aleksandra Lange, MD, David M. Coleman, MBBS, Przemyslaw Palka, MD,
Darryl J. Burstow, MBBS, James L. Wilkinson, MD, and Michael J. Godman, MD
A
mong the different echocardiographic techniques,
pulse-wave Doppler tissue echocardiography
(DTE) is regarded as the most accurate for the eval-
uation of mitral and tricuspid annulus motion.
1–7
The
aim of this study was to evaluate whether the Am-
platzer (AGA Medical Corporation, Golden Valley,
Minnesota) atrial septal defect (ASD) occluder
8 –11
affects mitral and tricuspid longitudinal annular ve-
locities assessed by pulse-wave DTE.
•••
A group of 35 patients (age 23 20 years, 18 men)
was studied before and within the first 2 days after
percutaneous ASD closure (Table 1). Forty-one age-
matched subjects served as a control group. All recruited
patients underwent successful percutaneous ASD closure
in 3 independent centers: The Royal Hospital for Sick
Children, Edinburgh, United Kingdom; Royal Children’s
Hospital, Melbourne, Australia; and The Prince Charles
Hospital, Brisbane, Australia. Data were analyzed in
each center separately by 3 experienced cardiologists
who were blinded to each other results. An Amplatzer
septal occluder was used in all patients (size 12 to 36
mm). None of the patients had a significant valvular
lesion (more than mild). Patients with ASDs who had
other forms of congenital heart disease and/or life-threat-
ening ventricular arrhythmias were not included in the
study. Before ASD closure, right ventricular systolic
pressure was 30 mm Hg in 16 patients (mean 34.3
7.8). Abnormal septal motion was noted in 22 patients (4
patients had paradoxic septal motion and 18 had flat-
tened septal motion).
The Amplatzer device size corresponds to the di-
ameter of the conjoint defect stretching waist and not
to the diameter of either the left atrial disc, which is 14
mm larger than the conjoint waist in devices 10 mm,
or the right atrial disc, which is 10 mm greater than the
waist in all device sizes. Thirteen of 34 patients with
ASDs were studied 6 to 12 months after device place-
ment to assess a potential change in measured param-
eters over time. All patients were invited for the fol-
low-up and those that returned were restudied.
All patients were examined at rest in the left lateral
decubitus position. Studies were performed with a
commercially available ultrasound system equipped
with DTE software (Acuson 128XP/10, Acuson Se-
quoia, Mountain View, California). A variable fre-
quency transducer (2.5 to 8.0 MHz) was used in all
M-mode and Doppler examinations. ASD dimensions
were established from combined apical and subcostal
views. Doppler studies (both mitral inflow and DTE)
were recorded using an apical 4-chamber view. A
standard technique was used to record mitral inflow.
Parameters measured were: peak E wave, peak A
wave, E-wave deceleration time, and isovolumic re-
laxation time. To record mitral annulus velocities by
DTE, a 2-dimensionally guided 10-mm Doppler gate
was placed at the site of the medial and lateral mitral
annulus and the lateral tricuspid annulus. For DTE
studies, the spectral pulsed Doppler signal was ad-
justed to obtain a Nyquist limit of 40 cm/s, with
low-wall filter settings and minimum optimal gain.
Parameters measured were peak velocities (centime-
ters per second) in early diastole in the medial mitral
annulus (E
mm
), lateral mitral annulus (E
ml
), and lateral
tricuspid annulus (E
tl
), and peak velocities in late
diastole (A
mm
,A
ml
,A
tl
).
1–7
The time from the begin-
ning of the QRS complex on the simultaneously re-
corded electrocardiogram to peak systolic velocity and
both the onset and the peak of diastolic annular ve-
locities was also calculated. All measurements were
obtained at end-expiration and averaged from 3 car-
diac cycles.
The data are expressed as mean value SD for
continuous variables and as frequency number (per-
centages) for dichotomous variables. Analysis of vari-
ance with Scheffe’s F adjustment for multiple com-
parisons was used to assess the differences between
age-matched controls and ASD patients’ pre- and
postpercutaneous device closure. Unpaired and paired
t tests were used when appropriate. Linear regression
From the Department of Cardiology, The Royal Hospital for Sick
Children, Edinburgh, United Kingdom; Department of Cardiology, The
Prince Charles Hospital, Brisbane, Australia; and Department of Car-
diology, Royal Children’s Hospital, Melbourne, Australia. Dr. Lange’s
address is: Heart Institute, St. Andrew’s War Memorial Hospital, 457
Wickham Terrace, Brisbane GPO Box 764, Queensland 4001,
Australia. E-mail: AlekLange@hotmail.com. Manuscript received May
23, 2002; revised manuscript received and accepted August 23,
2002.
TABLE 1 Clinical Characteristics of Study Subjects
Patients with ASD
(n = 35)
Controls
(n = 41)
Age (yrs) (range) 23 20 (3–70) 22 20 (1–70)
Men/Women 16/19 16/25
Atrial fibrillation 2 (6%) —
New York Heart Association
classification
0–I 23 (66%) —
II–III 12 (34%)
Heart rate (beats/min)
Pre-ASD device closure 85 20 75 16
Post-ASD device closure 81 19
Systolic blood pressure (mm hg) 120 18 118 10
Body surface area (m
2
) 1.40 0.57 1.43 0.53
Data are presented as a mean SD or number with percentage.
104 ©2003 by Excerpta Medica, Inc. All rights reserved. 0002-9149/03/$–see front matter
The American Journal of Cardiology Vol. 91 January 1, 2003 PII S0002-9149(02)03013-8